On November 6, 2025, Cui Xiaohao, Deputy Secretary of the CPC Shunyi District Committee, Secretary of the Party Leadership Group and Mayor of the Shunyi District Government, Deputy Secretary of the Working Committee of the Capital International Airport Economic Zone, and Director of the Administrative Committee of the Capital International Airport Economic Zone, visited AccuMedical Inc. (hereinafter “AccuMedical” or “we”) to conduct an in-depth research and exchange session. Centering on the theme of “Implementing the spirit of the Fourth Plenary Session of the 20th CPC Central Committee and accelerating the construction of a modern industrial system,” the visit aimed to promote the high-quality development of Shunyi District’s pharmaceutical and healthcare industries, identify enterprise needs, and empower industrial growth with precision.
Listening to AccuMedical’s Development Overview
During the visit, District Mayor Cui and his delegation toured AccuMedical’s product showroom and production workshop, gaining detailed insights into the company’s core product R&D, manufacturing processes, market expansion strategies, and future development plans.
Cui emphasized that enterprises should leverage their professional strengths, focus on specialized segments within the pharmaceutical and healthcare sectors, continuously optimize management models, strengthen market research and analysis, enhance technological innovation and R&D investment, and expand their market presence. He encouraged AccuMedical to maintain its strong growth momentum, play a leading and demonstrative role, and drive the overall advancement of the industrial chain.
AccuMedical CEO noted that technological advancement is the core competitiveness of the medical device industry. Since its founding, AccuMedical has focused on breakthroughs and improvements in key technologies and processes, with the goal of addressing unmet clinical needs. AccuMedical will continue to increase our R&D investment, refine product processes, and optimize our portfolio based on market demand in the future. Through continuous technological iteration and industrial chain collaboration, the company aim to deliver safer and more efficient clinical solutions, contributing to the high-quality development of the healthcare industry.
AccuMedical Inc. is an innovative medical device company specializing in neurointervention. Its product portfolio covers devices for hemorrhagic and ischemic stroke treatment as well as auxiliary access products, providing comprehensive solutions for clinical departments treating cerebrovascular diseases. Through independent R&D, AccuMedical has achieved groundbreaking innovations in multiple fields, including stent delivery systems, stent braiding, laser cutting, material surface modification, multi-segment variable-stiffness polymers, and liquid embolic polymers. Many of these innovations have been successfully transformed into core technologies with industry-leading advantages. Among its flagship products, Lattice Flow Diverter stands out for its unique technical features and innovative design, accelerating the quality improvement and localization of neurointerventional devices and bridging multiple technological gaps in China’s medical device industry.